Baicalein attenuates astroglial activation in the 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine-induced Parkinson's disease model by downregulating the activations of nuclear factor-κB, ERK, and JNK

Journal of Neuroscience Research

Volumn 92, Issue 1, 2014, Pages 130-139

  Lee, Eunjin ^a   Park, Hee Ra ^a   Ji, Seung Taek ^a   Lee, Yujeong ^a   Lee, Jaewon ^a  

^a Pusan National University   (South Korea)

Author keywords

ERK; JNK; Neuroinflammation; NF B; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BAICALEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTE CULTURE; ASTROGLIAL ACTIVATION; CELL ACTIVATION; CELL VIABILITY; CONTROLLED STUDY; DISEASE MODEL; DOPAMINERGIC NERVE CELL; DOWN REGULATION; ENZYME ACTIVATION; LOW DRUG DOSE; MALE; MICROGLIA; MOTOR PERFORMANCE; MOUSE; NERVE CELL CULTURE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ERK; JNK; NEUROINFLAMMATION; NF-ΚB; PARKINSON'S DISEASE;

ANIMALS; ASTROCYTES; DOWN-REGULATION; ENZYME INHIBITORS; FLAVANONES; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MPTP POISONING; NEURONS; NF-KAPPA B;

EID: 84888051964     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23307     Document Type: Article

References (54)

1. Amor S, Puentes F, Baker D, van der Valk P. 2010. Inflammation in neurodegenerative diseases. Immunology 129:154-169.
2. Blackwell TS, Christman JW. 1997. The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol 17:3-9.
3. Borlongan CV, Martinez R, Shytle RD, Freeman TB, Cahill DW, Sanberg PR. 1995. Striatal dopamine-mediated motor behavior is altered following occlusion of the middle cerebral artery. Pharmacol Biochem Behav 52:225-229.
4. Chang CL, Lin CS, Lai GH. 2012. Phytochemical characteristics, free radical scavenging activities, and neuroprotection of five medicinal plant extracts. Evid Based Complement Alternat Med 2012:984295.
5. Chen J, Tang XQ, Zhi JL, Cui Y, Yu HM, Tang EH, Sun SN, Feng JQ, Chen PX. 2006. Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ion-induced apoptosis by bcl-2-mitochondria-ROS-iNOS pathway. Apoptosis 11:943-953.
6. Chen SF, Hsu CW, Huang WH, Wang JY. 2008. Post-injury baicalein improves histological and functional outcomes and reduces inflammatory cytokines after experimental traumatic brain injury. Br J Pharmacol 155:1279-1296.
7. Cheng Y, He G, Mu X, Zhang T, Li X, Hu J, Xu B, Du G. 2008. Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile. Neurosci Lett 441:16-20.
8. Choi JY, Park CS, Kim DJ, Cho MH, Jin BK, Pie JE, Chung WG. 2002. Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate. Neurotoxicology 23:367-374.
9. Choi SY, Son TG, Park HR, Jang YJ, Oh SB, Jin B, Lee J. 2012. Naphthazarin has a protective effect on the 1-methyl-4-phenyl-1, 2, 3, 4-tetrahydropyridine-induced Parkinson's disease model. J Neurosci Res 90:1842-1849.
10. Dehmer T, Heneka MT, Sastre M, Dichgans J, Schulz JB. 2004. Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation. J Neurochem 88:494-501.
11. Dhawan P, Richmond A. 2002. A novel NF-kappa B-inducing kinase-MAPK signaling pathway upregulates NF-kappa B activity in melanoma cells. J Biol Chem 277:7920-7928.
12. Gadea A, Schinelli S, Gallo V. 2008. Endothelin-1 regulates astrocyte proliferation and reactive gliosis via a JNK/c-Jun signaling pathway. J Neurosci 28:2394-2408.
13. Gilmore TD. 2006. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 25:6680-6684.
14. + increases alpha-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells. Brain Res 935:32-39.
15. Hsieh CJ, Hall K, Ha T, Li C, Krishnaswamy G, Chi DS. 2007. Baicalein inhibits IL-1beta- and TNF-alpha-induced inflammatory cytokine production from human mast cells via regulation of the NF-kappaB pathway. Clin Mol Allerg 5:5.
16. Hunot S, Hirsch EC. 2003. Neuroinflammatory processes in Parkinson's disease. Ann Neurol 53(Suppl 3):S49-S58; discussion S58-S60.
17. Ip YT, Davis RJ. 1998. Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr Opin Cell Biol 10:205-219.
18. Karunakaran S, Saeed U, Mishra M, Valli RK, Joshi SD, Meka DP, Seth P, Ravindranath V. 2008. Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated mice. J Neurosci 28:12500-12509.
19. Khairnar A, Plumitallo A, Frau L, Schintu N, Morelli M. 2010. Caffeine enhances astroglia and microglia reactivity induced by 3, 4-methylenedioxymethamphetamine ("ecstasy") in mouse brain. Neurotox Res 17:435-439.
20. Kim DY, Hong GU, Ro JY. 2011. Signal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40L. J Neuroinflamm 8.
21. Kim HS, Son TG, Park HR, Lee Y, Jung Y, Ishigami A, Lee J. 2012. Senescence marker protein 30 deficiency increases Parkinson's pathology by impairing astrocyte activation. Neurobiol Aging 34:1177-1183.
22. Kim JH, Na HK, Pak YK, Lee YS, Lee SJ, Moon A, Surh YJ. 2008. Roles of ERK and p38 mitogen-activated protein kinases in phorbol ester-induced NF-kappaB activation and COX-2 expression in human breast epithelial cells. Chem Biol Interact 171:133-141.
23. Kim SJ, Sung JY, Um JW, Hattori N, Mizuno Y, Tanaka K, Paik SR, Kim J, Chung KC. 2003. Parkin cleaves intracellular alpha-synuclein inclusions via the activation of calpain. J Biol Chem 278:41890-41899.
24. Kohutnicka M, Lewandowska E, Kurkowska-Jastrzebska I, Czlonkowski A, Czlonkowska A. 1998. Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP). Immunopharmacology 39:167-180.
25. Lee YJ, Han SB, Nam SY, Oh KW, Hong JT. 2010. Inflammation and Alzheimer's disease. Arch Pharm Res 33:1539-1556.
26. Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, Dawson VL, Dawson TM, Przedborski S. 1999. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 5:1403-1409.
27. Lin CC, Shieh DE. 1996. The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin. Am J Chin Med 24:31-36.
28. Lin MS, Lee YH, Chiu WT, Hung KS. 2011. Curcumin provides neuroprotection after spinal cord injury. J Surg Res 166:280-289.
29. Lofrumento DD, Saponaro C, Cianciulli A, De Nuccio F, Mitolo V, Nicolardi G, Panaro MA. 2011. MPTP-induced neuroinflammation increases the expression of pro-inflammatory cytokines and their receptors in mouse brain. Neuroimmunomodulation 18:79-88.
30. Lu KT, Ko MC, Chen BY, Huang JC, Hsieh CW, Lee MC, Chiou RY, Wung BS, Peng CH, Yang YL. 2008. Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. J Agric Food Chem 56:6910-6913.
31. Massano J, Bhatia KP. 2012. Clinical approach to Parkinson's disease: features, diagnosis, and principles of management. Cold Spring Harbor Perspect Med 2:a008870.
32. Mattson MP, Cheng A. 2006. Neurohormetic phytochemicals: low-dose toxins that induce adaptive neuronal stress responses. Trends Neurosci 29:632-639.
33. Mattson MP, Wang H, Michaelis EK. 1991. Developmental expression, compartmentalization, and possible role in excitotoxicity of a putative NMDA receptor protein in cultured hippocampal neurons. Brain Res 565:94-108.
34. Moon M, Kim HG, Hwang L, Seo JH, Kim S, Hwang S, Lee D, Chung H, Oh MS, Lee KT, Park S. 2009. Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation. Neurotox Res 15:332-347.
35. Mu X, He GR, Yuan X, Li XX, Du GH. 2011. Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice. Pharmacol Biochem Behav 98:286-291.
36. Oh SB, Park HR, Jang YJ, Choi SY, Son TG, Lee J. 2013. Baicalein attenuates impaired hippocampal neurogenesis and the neurocognitive deficits induced by gamma-ray radiation. Br J Pharmacol 168:421-431.
37. Pappas E, Schaich KM. 2009. Phytochemicals of cranberries and cranberry products: characterization, potential health effects, and processing stability. Crit Rev Food Sci Nutr 49:741-781.
38. Park SJ, Kim DH, Kim JM, Shin CY, Cheong JH, Ko KH, Ryu JH. 2010. Mismatch between changes in baicalein-induced memory-related biochemical parameters and behavioral consequences in mouse. Brain Res 1355:141-150.
39. Peng J, Andersen JK. 2003. The role of c-Jun N-terminal kinase (JNK) in Parkinson's disease. IUBMB Life 55:267-271.
40. Peterson LJ, Flood PM. 2012. Oxidative stress and microglial cells in Parkinson's disease. Mediators Inflamm 2012:401264.
41. Rappold PM, Tieu K. 2010. Astrocytes and therapeutics for Parkinson's disease. Neurotherapeutics 7:413-423.
42. Sakata N, Kawasome H, Terada N, Gerwins P, Johnson GL, Gelfand EW. 1999. Differential activation and regulation of mitogen-activated protein kinases through the antigen receptor and CD40 in human B cells. Eur J Immunol 29:2999-3008.
43. Shi C, Zhang YX, Zhang ZF. 2009. [Effect of phosphorylated-ERK1/2 on inducible nitric oxide synthase expression in the substantia nigra of mice with MPTP-induced Parkinson disease]. Nan Fang Yi Ke Da Xue Xue Bao 29:60-63.
44. Son TG, Park HR, Kim SJ, Kim K, Kim MS, Ishigami A, Handa S, Maruyama N, Chung HY, Lee J. 2009. Senescence marker protein 30 is upregulated in kainate-induced hippocampal damage through ERK-mediated astrocytosis. J Neurosci Res 87:2890-2897.
45. Suarez I, Bodega G, Ramos JA, Fernandez-Ruiz JJ, Fernandez B. 2000. Neuronal and astroglial response to pre- and perinatal exposure to delta-9-tetra-hydrocannabinol in the rat substantia nigra. Dev Neurosci 22:253-263.
46. Tapia-Gonzalez S, Giraldez-Perez RM, Cuartero MI, Casarejos MJ, Mena MA, Wang XF, Sanchez-Capelo A. 2011. Dopamine and alpha-synuclein dysfunction in Smad3 null mice. Mol Neurodegener 6:72.
47. Teismann P, Schulz JB. 2004. Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation. Cell Tissue Res 318:149-161.
48. Tripanichkul W, Jaroensuppaperch EO, Finkelstein DI. 2008. Estrogen enhances the number of nigral dopaminergic neurons of adult male mice without affecting nigral neuroglial number and morphology. Neurosci Lett 435:210-214.
49. Tufekci KU, Meuwissen R, Genc S, Genc K. 2012. Inflammation in Parkinson's disease. Adv Protein Chem Struct Biol 88:69-132.
50. +-induced apoptosis by AKT/GSK-3beta/JNK signaling. Apoptosis 15:1470-1479.
51. Xiong Z, Jiang B, Wu PF, Tian J, Shi LL, Gu J, Hu ZL, Fu H, Wang F, Chen JG. 2011. Antidepressant effects of a plant-derived flavonoid baicalein involving extracellular signal-regulated kinases cascade. Biol Pharm Bull 34:253-259.
52. +-induced apoptotic cell death in neuroblastoma cells SH-EP1 through JNK and c-Jun/AP-1. Neurochem Int 56:128-134.
53. Yasuda Y, Shimoda T, Uno K, Tateishi N, Furuya S, Yagi K, Suzuki K, Fujita S. 2008. The effects of MPTP on the activation of microglia/astrocytes and cytokine/chemokine levels in different mice strains. J Neuroimmunol 204:43-51.
54. Zhang Z, Cui W, Li G, Yuan S, Xu D, Hoi MP, Lin Z, Dou J, Han Y, Lee SM. 2012. Baicalein protects against 6-OHDA-induced neurotoxicity through activation of Keap1/Nrf2/HO-1 and involving PKCalpha and PI3K/AKT signaling pathways. J Agric Food Chem 60:8171-8182.